Comparison of suppository morphine and intravenous pethidine on postoperative pai
Not Applicable
Completed
- Conditions
- Pain.Acute pain
- Registration Number
- IRCT2013012712295N1
- Lead Sponsor
- Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
the age of 20 to 60 years; weight of 70 to 90 Kg; candidate of laparascopic cholecystectomy; anesthesia risk 1 or 2 Exclusion criteria: sensitivity to the opioids; liver or kidney failure; the consumption of opioid before surgery; acute respiratory failure; the consumption of mono amin oxidase(MAO) enzyme inhibitor drugs at the same time or during the last 14 days ago
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative Pain. Timepoint: 0 , 1 , 2 , 4 and 6 hours after extubation. Method of measurement: Visual Analog Scale.
- Secondary Outcome Measures
Name Time Method Amount of received opioid after surgery for pain control. Timepoint: during 48 hours after surgery. Method of measurement: Milligram.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie suppository morphine and intravenous pethidine for postoperative pain in IRCT2013012712295N1?
How does suppository morphine's efficacy compare to intravenous pethidine in IRCT2013012712295N1 for postoperative pain after laparoscopic cholecystectomy?
What biomarkers predict response to suppository morphine versus intravenous pethidine in IRCT2013012712295N1 postoperative pain management?
What adverse events and management strategies are associated with suppository morphine and intravenous pethidine in IRCT2013012712295N1 postoperative settings?
What is the comparative safety and efficacy of suppository morphine and intravenous pethidine with other opioid analgesics in IRCT2013012712295N1 postoperative pain studies?